Table 2. Cancers expressing increased genomic Usmg5 copy number in Oncomine cancer genomics database.
| Classification | Cancer type | DNA copy number | *Gene rank % | Oncomine datasets |
|---|---|---|---|---|
| Brain | Astrocytoma | 4,40 | 1 | Beroukhim Brain [31] |
| Astrocytoma | 4,50 | 3 | TCGA Brain 2 [N/A] | |
| Astrocytoma | 4,36 | 4 | Kotliarov Brain [32] | |
| Astrocytoma | 4,07 | 12 | Northcott Brain 4 [33] | |
| Head and Neck Cancer Cell Line | 4,13 | 2 | Beroukhim Multi-cancer [34] | |
| Head and Neck Cancer | 4,11 | 5 | Beroukhim Multi-cancer [34] | |
| Head and Neck Cancer | 4,13 | 24 | Barretina CellLine 2 [35] | |
| Mixed Glioma | 4,89 | 1 | TCGA Brain 2 [N/A] | |
| Oligodendroglial Tumor | 4,73 | 2 | Kotliarov Brain [32] | |
| Oligodendroglial Tumor | 5,07 | 3 | TCGA Brain 2 [N/A] | |
| Oligodendroglial Tumor | 4,29 | 7 | Beroukhim Brain [31] | |
| Pancreas | Pancreatic Cancer | 4,19 | 6 | Barretina CellLine 2 [35] |
| Liver | Liver Cancer | 4,33 | 4 | Rothenberg CellLine [38] |
| Liver Cancer | 4,18 | 7 | Barretina CellLine 2 [35] | |
| Liver Cancer Precursor | 4,10 | 29 | Chiang Liver 2 [46] | |
| Sarcoma | Dedifferentiated Liposarcoma | 4,12 | 9 | Barretina Sarcoma 2 [37] |
| Myxoid/Round Cell Liposarcoma | 4,12 | 15 | Barretina Sarcoma 2 [37] | |
| Sarcoma | 4,12 | 8 | Barretina CellLine 2 [35] | |
| Sarcoma | 4,12 | 12 | Wooster CellLine 2 [N/A] | |
| Sarcoma | 4,10 | 13 | Rothenberg CellLine [38] | |
| Sarcoma Cell Line | 4,14 | 24 | Beroukhim Multi-cancer [34] | |
| Kidney | Kidney Cancer | 4,67 | 2 | Neale Multi-cancer 2 [43] |
| Kidney Cancer | 4,20 | 12 | Barretina CellLine 2 [35] | |
| Hereditary Clear Cell Renal Cell Carcinoma | 4,07 | 26 | Beroukhim Renal 2 [47] | |
| Lung | Non-Small Cell Lung Carcinoma | 4,13 | 10 | Weiss Lung [40] |
| Non-Small Cell Lung Carcinoma | 4,18 | 12 | TCGA Lung 2 [N/A] | |
| Gastric | Gastric Adenocarcinoma | 4,06 | 14 | Deng Gastric [36] |
| Gastric Mixed Adenocarcinoma vs. Normal | 4,10 | 15 | Deng Gastric [36] | |
| Gastrointestinal Stromal Tumor | 4,40 | 17 | Barretina Sarcoma 4 [37] | |
| Colon Adenocarcinoma | 4,06 | 14 | TCGA Colorectal 2 [N/A] | |
| Colorectal Cancer | 4,13 | 13 | Rothenberg CellLine [38] | |
| Colorectal Cancer | 4,07 | 18 | Barretina CellLine 2 [35] | |
| Colorectal Cancer | 4,28 | 13 | Jaiswal Multi-cancer [39] | |
| Leukemia | Leukemia | 4,46 | 5 | Neale Multi-cancer 3 [43] |
| Refractory Anemia with Excess Blasts-1 vs. Normal | 4,13 | 13 | Yoshida Leukemia [44] | |
| Chronic Myelomonocytic Leukemia-1 vs. Normal | 4,12 | 14 | Yoshida Leukemia [44] | |
| Leukemia Cell Line | 4,17 | 20 | Beroukhim Multi-cancer [34] | |
| Plasma Cell Leukemia | 4,09 | 21 | Chapman Myeloma 2 [45] | |
| Breast | Mixed Lobular and Ductal Breast Carcinoma | 4,11 | 7 | Nikolsky Breast [41] |
| Papillary Breast Carcinoma | 4,08 | 11 | TCGA Breast 2 [N/A] | |
| Mucinous Breast Carcinoma | 4,08 | 20 | Curtis Breast 2 [42] | |
| Lobular Breast Carcinoma | 4,07 | 23 | TCGA Breast 2 [N/A] | |
| Ductal Breast Carcinoma in Situ | 4,06 | 24 | Curtis Breast 2 [42] | |
| Ovarian | Ovarian Cancer | 4,09 | 16 | Beroukhim Multi-cancer [34] |
| Endometrial Endometrioid Adenocarcinomavs. Normal | 4,10 | 17 | TCGA Endometrium [N/A] | |
| Endometrial Serous Adenocarcinoma vs. Normal | 4,16 | 29 | TCGA Endometrium [N/A] | |
| Lymphoma | Lymphoma | 4,15 | 21 | Wooster CellLine 2 [N/A] |
| Lymphoma | 4,08 | 28 | Barretina CellLine 2 [35] | |
| Other | Oral Cavity Squamous Cell Carcinoma vs. Normal | 4,03 | 48 | Peng Head-Neck 2 [48] |
N/A indicating not available.
* Indicating % of top genes duplicated, within which Usmg5 was ranked.